Edition:
United States

Intellia Therapeutics Inc (NTLA.OQ)

NTLA.OQ on NASDAQ Stock Exchange Global Market

30.79USD
20 Jun 2018
Change (% chg)

-- (--)
Prev Close
$30.79
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
332,318
52-wk High
$35.99
52-wk Low
$13.53

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.55 December 21 Jun 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 3 3 3 3
(2) OUTPERFORM 3 3 3 3
(3) HOLD 1 1 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.71 1.88 1.88

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 5 6.63 7.90 5.00 5.00
Quarter Ending Sep-18 5 11.34 25.40 5.00 16.00
Year Ending Dec-18 6 36.42 56.10 29.16 43.70
Year Ending Dec-19 5 33.91 46.00 25.00 37.25
Earnings (per share)
Quarter Ending Jun-18 6 -0.55 -0.50 -0.59 -0.50
Quarter Ending Sep-18 6 -0.48 -0.16 -0.64 -0.22
Year Ending Dec-18 6 -2.03 -1.65 -2.33 -1.41
Year Ending Dec-19 6 -2.60 -2.11 -3.09 -2.16

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 6.27 7.47 1.19 19.05
Quarter Ending Dec-17 7.22 6.67 0.55 7.61
Quarter Ending Sep-17 5.88 7.32 1.44 24.44
Quarter Ending Jun-17 5.82 5.92 0.09 1.58
Quarter Ending Mar-17 5.30 6.22 0.91 17.26
Earnings (per share)
Quarter Ending Mar-18 -0.58 -0.51 0.07 -11.57
Quarter Ending Dec-17 -0.42 -0.61 0.19 -45.83
Quarter Ending Sep-17 -0.50 -0.44 0.06 -11.29
Quarter Ending Jun-17 -0.41 -0.45 0.03 -8.43
Quarter Ending Mar-17 -0.34 -0.36 0.02 -5.88

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 6.63 6.63 6.63 6.39 5.00
Quarter Ending Sep-18 11.34 11.34 11.34 11.25 16.00
Year Ending Dec-18 36.42 36.42 36.42 30.67 43.70
Year Ending Dec-19 33.91 33.91 33.91 33.74 37.25
Earnings (per share)
Quarter Ending Jun-18 -0.55 -0.55 -0.55 -0.62 -0.50
Quarter Ending Sep-18 -0.48 -0.48 -0.48 -0.55 -0.22
Year Ending Dec-18 -2.03 -2.03 -2.03 -2.29 -1.41
Year Ending Dec-19 -2.60 -2.60 -2.60 -2.81 -2.16

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0